(2011) Comparison of a fluorogenic anti-FXa assay with
(2011) Comparison of a fluorogenic anti-FXa assay with
(2011) Comparison of a fluorogenic anti-FXa assay with
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
[25] Kovacs MJ, Keeney M, MacKinnon K, Boyle E. Three different chromogenic methods<br />
do not give equivalent <strong>anti</strong>-Xa levels for patients on therapeutic low molecular weight<br />
heparin (dalteparin) or unfractionated heparin. Clin Lab Haematol 1999;21:55-60.<br />
[26] Kitchen S, Iampietro R, Woolley AM, Preston FE. Anti Xa monitoring during treatment<br />
<strong>with</strong> low molecular weight heparin or danaparoid: Inter-<strong>assay</strong> variability. Thromb Haemost<br />
1999;82:1289-93.<br />
[27] Flom-Halvorsen HI, Ovrum E, Abdelnoor M, Bjornsen S, Brosstad F. Assessment <strong>of</strong><br />
heparin <strong>anti</strong>coagulation: <strong>Comparison</strong> <strong>of</strong> two commercially available methods. Ann Thorac<br />
Surg 1999;67:1012-6.<br />
21
Change language